Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Central Clinic
    3. >
  3. Blood Purification Center

Journal
BooK
Presentation
    （Last updated : 2023-11-28 16:40:54）
  Kuragano Takahiro
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Current Topics in Therapeutic Plasmapheresis 2014/02
2. Original article　 Dysregulated iron metabolism in patients on hemodialysis. 2015/05
3. Original article　 Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited. 2015/07
4. Original article　 The Authors Reply 2015/07
5. Original article　 Body mass index modifies an association between self-reported regular exercise and proteinuria. 2015/12
6. Original article　 Association between changes in serum levels of N-terminal pro-brain natriuretic peptide(NT-proBNP) and heart rate in hemodialysis patients 2016/03
7. Original article　 ESA hyporesponsiveness is associated with adverse events in maintenance hemodialysis (MHD) patients, but not with iron storage. 2016/03
8. Original article　 Iron localization and infectious disease in chronic kidney disease patients. 2016/04
9. Original article　 Serum uric acid level predicts progression of IgA nephropathy in females but not in males. 2016/08
10. Original article　 Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited. 2016/10
11. Original article　 The association of alcohol and smoking with CKD in a Japanese nationwide cross-sectional survey. 2017/08
12. Original article　 Interplay of adipocyte and hepatocyte: Leptin upregulates hepcidin. 2018/01
13. Original article　 Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24 (IL-24), with/without TNF-alpha. 2018/01
14. Original article　 Factors associated with serum magnesium and vascular stiffness in maintenance hemodialysis patients. 2018/07
15. Original article　 Importance of physiological erythropoiesis in the treatment of chronic kidney disease-associated anemia. 2018/07
16. Original article　 Oral versus intravenous iron supplementation for the treatment of iron deficiency anemia in patients on maintenance hemodialysis-effect on fibroblast growth factor-23 metabolism. 2018/07
17. Original article　 White-coat hypertension and albuminuria; lessons from the Hisayama and Ohasama studies. 2018/07
18. Original article　 Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease. 2019/01
19. Original article　 Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention. 2019/01
20. Original article　 Misdistribution of iron and oxidative stress in chronic kidney disease. 2019/03
21. Original article　 Anemia management considering the pathophysiology of elderly chronic kidney disease patients. 2019/04
22. Original article　 Clinical benefit of an adsorptive technique for elderly long-term hemodialysis patients. 2019/04
23. Original article　 Current Topics in Vascular Access: Superficialization of Arteriovenous Fistula. 2019/04
24. Original article　 Effect of progression in malnutrition and inflammatory conditions on adverse events and mortality in patients on maintenance hemodialysis. 2019/04
25. Original article　 Inhibition of the Mammalian Target of Rapamycin May Augment the Increase in Soluble Klotho Levels in Renal Transplantation Recipients. 2019/04
26. Original article　 Predilution on-Line hemodiafiltration improves albumin redox in maintenance hemodialysis patients. 2019/04
27. Original article　 Preface. 2019/04
28. Original article　 The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease. 2019/04
29. Original article　 Circadian rhythm and CKD: is melatonin a key player or bi-player? 2019/06
30. Original article　 Intravenous iron and maintenance hemodialysis. 2019/06
31. Original article　 Health economic evalution of peritoneal dialysis based on cost-effectiveness in Japan: a preliminary study 2019/09
32. Original article　 Potential hazards of recent trends in liberal iron use for renal anemia. 2020/08
33. Original article　 Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients. 2020/09
34. Introduction　 The pathogenesis of CKD complications; Attack of dysregulated iron and phosphate metabolism. 2020/09
35. Original article　 Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria 2020/10
36. Original article　 The pharmacokinetics of oral metronidazole in patients with metronidazole-induced encephalopathy undergoing maintenance hemodialysis. 2020/10
37. Original article　 Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis. 2021/04
38. Original article　 Association between bone mineral density of the distal third of the radius and mortality in patients on hemodialysis, a retrospective cohort study. 2021/07
39. Original article　 Shared decision making for the initiation and continuation of dialysis: a proposal from the Japanese Society for Dialysis Therapy. 2021/10
40. Original article　 Melatonin and gestational hypertension. 2021/11
41. Original article　 Hemodiafiltration improves low levels of health-related quality of life (Qol) and nutritional conditions of hemodialysis patients. 2022/02
42. Original article　 Long-acting erythropoiesis-stimulating agent (ESA) induces physiological erythropoiesis via improvement of iron availability. 2022/05
43. Case report　 TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report 2022/07
44. Original article　 Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study. 2022/12
45. Original article　 Not baseline but time-dependent erythropoiesis-stimulating agent responsiveness predicts cardiovascular disease in hemodialysis patients receiving epoetin beta pegol: A multicenter prospective PARAMOUNT-HD Study 2023/03
46. Original article　 Anemia treatment, hemoglobin variability, and clinical events in non-dialysis-dependent chronic kidney disease patients in Japan. 2023/07
Display 5 items
Display all(46)
■ BooK
1. Contributor　 renal anemia「TODAY'S THERAPY 2015」 2015/04
■ Presentation
1. Hb levels and dose of iron associated with adverse events are different between younger and elderly hemodialysis patients （General Lecture） 2016/05/22
2. Pathophysiology of anemia in a mouse model of chronic kidney disease ; hepcidin and erythropoiesis （General Lecture） 2016/05/22
3. Additional therapy of β2-microglobulin adsorption column on online hemodiafiltration improved persistent pain of dialysis-related amyloidosis （General Lecture） 2016/05/23
4. Efficacy of steroid therapy for IgA naphropathy therapy （General Lecture） 2016/05/23
5. Comparison of Hb levels and dose of iron associated with adverse events between younger and elderly hemodialysis patients （General Lecture） 2016/11/19
6. Dysregulated iron metabolism in bone marrow of a mouse model of chronic kidney disease （General Lecture） 2016/11/19
7. The association between dialysis session time and the risk for hospitalization and death in maintenance hemodialysis （General Lecture） 2016/11/19
8. Acute kidney injury and remission of proteinuria in adult-onset minimal change disease;a multicenter retrospective cohort study. （Poster presentation，General Lecture） 2017/06/04
9. Determination of hepcidin/ferritin ratio in patients undergoing maintenance hemodialysis. （Poster presentation，General Lecture） 2017/06/04
10. Iron stimulation enhanced calcification in human vascular smooth muscle cells. （Poster presentation，General Lecture） 2017/06/04
11. The impact of dose of ESA and iron on the risk of adverse events of hemodialysis patients. （Oral presentation，General Lecture） 2017/06/04
12. Dysregulated erythroid differentiation and iron metabolism in anemia of chronic kidney disease(CKD). （Poster presentation，General Lecture） 2017/06/05
13. Determinants of hepcidin/ferritin ratio in patients undergoing maintenance hemodialysis. （Poster presentation，General Lecture） 2017/11/04
14. Efficacy of steroid therapy for IgA nephropathy. （Poster presentation，General Lecture） 2017/11/04
15. The impact of dose of ESA and iron on the risk of adverse events in hemodialysis patients. （Poster presentation，General Lecture） 2017/11/04
16. Fibroblast Growth Factor-23 Is Related With Bone Mineral Content Of End Stage Renal Disease Patients On Haemodialysis. （Poster presentation，General Lecture） 2018/05/25
17. Iron-induced calcification in human aortic vascular smooth muscle cells through interleukin-24(IL-24). （Poster presentation，General Lecture） 2018/05/25
18. Presence of Campylobacter rectus and cnm-positive Streptococcus mutans strains in oral cavity was associated with urinary protein levels in IgAN patients. （Poster presentation，General Lecture） 2018/05/26
19. The relationship between non-transferrin bound iron (NTBI) and iron utilization for erythropoiesis in maintenance hemodialysis patients. （Poster presentation，General Lecture） 2018/05/26
20. Mammalian Target of Rapamycin (mTOR) Inhibitor might Augment Klotho Levels of Kidney Transplant Recipients. （Poster presentation，General Lecture） 2018/10/26
21. Zinc Deficiency is a Risk for Vascular Access Failure in Hemodialysis Patients. （Poster presentation，General Lecture） 2018/10/26
22. Iron stimulation calcification in human aortic vascular smooth muscle cells through interleukin-24(IL-24). （Poster presentation，General Lecture） 2018/10/27
23. The relationship between non-transferrin bound iron (NTBI) and iron utilization for erythropoiesis in maintenance hemodialysis patients. （Oral presentation，General Lecture） 2018/10/27
24. Prevalence of Triglyceride deposit cardiomyovasculopathy in chronic kidney disease patients （Oral presentation，General Lecture） 2019/03/16
25. Predilution on-line hemodiafiltration improves health-related quality of life (HRQoL) in the patients undergoing hemodialysis. （Poster presentation，General Lecture） 2019/06/14
26. Prevalence of periodontal disease bacteria in tonsils of IgA nephropathy patients. （Poster presentation，General Lecture） 2019/06/14
27. Prevalence of triglyceride deposit cardiomyovasculopathy in chronic kidney disease patients. （Poster presentation，General Lecture） 2019/06/14
28. Zinc deficiency may implicate vascular access failure after vascular access intervention in haemodialysis patients. （Poster presentation，General Lecture） 2019/06/14
29. Intravenous streptcoccus mutans in rats induced glomeloronephlitis like IgA nephropathy or infection-related glomerulonephritis. （Poster presentation，General Lecture） 2019/06/15
30. Long-acting erythropoiesis-stimulating agent (ESA) induced the physiological erythropoiesis via improvemen of iron availability. （Poster presentation，General Lecture） 2019/06/15
31. Polymorphism in the human matrix gla protein gene Is associated with the progression of osteoporosis in hemodialysis patients （Poster presentation，General Lecture） 2019/11/07
32. Prognostic evaluation by different target hemoglobin levels During treatment with epoetin beta pegol in hemodialysis patients with ESA hyporesponsiveness: PARAMOUNT-HD Study （Oral presentation，General Lecture） 2019/11/07
33. Predilution online hemodiafiltration improves health-related quality of life (HRQoL) in patients undergoing hemodialysis （Poster presentation，General Lecture） 2019/11/08
34. Prevalence of periodontal disease bacteria in tonsils of IgA nephropathy patients （Poster presentation，General Lecture） 2019/11/08
35. Long-acting erythropoiesis-stimulating agent (ESA) induced the physiological erythropoiesis via an improvement of iron availability （Poster presentation，General Lecture） 2019/11/09
36. Dental caries induced by CNM-positive streptococcus mutans derived from IgA nephropathy patients in rats induced gloperulonephritis like IgA nephropathy. （Web announcement，General Lecture） 2020/06/06
37. ESA hyporesposiveness and clinical outcomes during treatment with epoetin beta pegol in hemodialysis patients: a multicenter prospective study; paramount-HD study. （Web announcement，General Lecture） 2020/06/06
38. Low phosphate and low calcium levels predict a higher risk for cardiovascular events of maintenance hemodialysis patients. （Web announcement，General Lecture） 2020/06/06
39. The correlation between the management of comorbidities and the progression of the renal dysfunction or adverse events of chronic kidney disease. （Web announcement，General Lecture） 2020/06/06
40. The effect of smoking upon CKD in a Japanese nationwide 6-years follow up servey. （Web announcement，General Lecture） 2020/06/06
41. Low phosphate and low calcium levels predict higher risk for adverse events of maintenance hemodialysis （Web announcement，General Lecture） 2020/10/22
42. Anemia treatment and hemoglobin in non-dialysis dependent chronic kidney disease patients – A nationwide hospital- based cohort study. （Web announcement，General Lecture） 2023/03/30
43. Treatment patterns and clinical events in non-dialysis-dependent CKD patients with elevated C-reactive protein and anemia: A nationwide hospital-based cohort study in Japan. （Poster presentation，General Lecture） 2023/11/02
44. Association between the fibrosis-4 (FIB-4) score and ≥20% decline in the estimated glomerular filtration rate in the general population with abdominal adiposity. （Poster presentation，General Lecture） 2023/11/03
Display 5 items
Display all(44)
mail